Northwest Pipe Company Announces the Sale of Its Denver

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Northwest Pipe Company Announces the Sale of Its Denver Property

VANCOUVER, WA--(Marketwired - Oct 5, 2016) - Northwest Pipe Company ( NASDAQ : NWPX ) announced today it has sold its Denver real property for a purchase price of $14.4 million. The Company will lease the property back from the buyer until December 31, 2016, with two options to extend the lease-back period by 30 days each, in order to conclude production at the facility and complete final shipments. Approximately 20% of the Company's steel water pipe production capacity will be reduced with this sale.

"As the market leader, we have taken out capacity in a market that has been oversupplied for an extended period of time. This action allows us to continue to sharpen our focus on margin over volume," said Scott Montross, Northwest Pipe Company's President and CEO. "The proceeds from this sale will provide us greater financial flexibility for future opportunities in the water and wastewater infrastructure markets." 

About Northwest Pipe Company Northwest Pipe Company is the largest manufacturer of engineered steel pipe water systems in North America. The Company's Water Transmission manufacturing facilities are strategically positioned to meet North America's growing needs for water and wastewater infrastructure. The Company serves a wide range of markets and their solution-based products are a good fit for applications including: water transmission, plant piping, tunnels, and river crossings. The Company is headquartered in Vancouver, Washington and has manufacturing facilities across the United States and one manufacturing facility in Mexico.

Forward-Looking Statements Statements in this press release by Scott Montross are "forward-looking" statements within the meaning of the Securities Litigation Reform Act of 1995 and Section 21E of the Exchange Act that are based on current expectations, estimates and projections about our business, management's beliefs, and assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements as a result of a variety of important factors. While it is impossible to identify all such factors, those that could cause actual results to differ materially from those estimated by us include changes in demand and market prices for our products, product mix, bidding activity, the timing of customer orders and deliveries, production schedules, the price and availability of raw materials, price and volume of imported product, excess or shortage of production capacity, international trade policy and regulations, our ability to increase margins and reduce costs as a result of the sale of the Denver facility, and other risks discussed in our Annual Report on Form 10-K for the year ended December 31, 2015 and from time to time in our other Securities and Exchange Commission filings and reports. Such forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. If we do update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections with respect thereto or with respect to other forward-looking statements. 

For more information, visit www.nwpipe.com .

Contact : Robin Gantt Chief Financial Officer (360) 397-6325

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 114

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 65

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Burtch Works Joins Databricks: Fueling AI Success

Updated Category News Views 20

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

Continue Reading
Bimbo Bakeries Teamsters Gear Up for Strike in NJ

Updated Category News Views 102

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Continue Reading
Zura Bio Faces Tough Road After Trial Failure

Updated Category News Views 155

Investor Dilemma: ZURA Takes a Nosedive November 9, 2026, wasn't a day to remember for anyone holding shares in Zura Bio. If ever there's a classic lesson in biotech investing's volatility, this is it: shares of Zura Biotech (NASDAQ:ZURA) cratered by about 72% after news broke that their much-hyped Phase 2 TibuSHIELD trial for tibulizumab hit the skids. For a company that...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 56

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 115

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 126

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Mesh Security Bolsters Team with Five Cybersecurity Experts

Updated Category News Views 252

New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...

Continue Reading
Charitable Giving Turbocharges E-commerce Conversion Rates

Updated Category News Views 50

Charitable Giving: The Secret Sauce for E-commerce Success In an e-commerce arena teeming with bland sameness, charitable giving is proving to be a game-changing hook. That's right—brands partnering with Change and DailyKarma have found a magic formula where customers flourish and causes benefit. With over $7.4 million in donations spread across more than 3 million...

Continue Reading

Top 5 Most Recently Viewed Articles

Get A Drip Names New CMO Amid Longevity Boom

Updated Category News Views 21

So, here's a curveball in the health gig—longevity's caught a second wind. And who's riding the wave? Get A Drip, the UK hotshot in the wellness league. They've just snagged Dr. Luke Pratsides as their new Chief Medical Officer. Imagine adding a sharp arrow to the quiver at a time when folks are head-over-heels for living longer and staying healthier. Longevity at the...

Continue Reading
Class Action Lawsuit Alert for Marex Group Investors - Act Now!

Updated Category News Views 157

Attention Investors: Marex Group Class Action Lawsuit Announced Investors in Marex Group plc (NASDAQ: MRX) should take note of an important development. A class action lawsuit has been initiated against Marex on behalf of those who purchased shares during the specified time frame. This legal action addresses serious allegations of financial misconduct, leading to...

Continue Reading
Navigating Political Challenges: Macron's Strategy with Barnier

Updated Category News Views 69

Understanding Barnier's New Role in French Politics After navigating the intricate Brexit negotiations, Michel Barnier has now stepped into a demanding role as Prime Minister. This position is crucial for tackling the urgent challenges within France's divided political environment. Challenges Awaiting Barnier Emmanuel Macron selected Barnier to steer his government...

Continue Reading
Verona Pharma Receives Shareholder Approval for Merck Deal

Updated Category News Views 211

Verona Pharma's Shareholders Greenlight Merck Acquisition In a significant step for Verona Pharma, shareholders have given the green light for the proposed acquisition by Merck & Co., marking a pivotal moment in the biopharmaceutical company's journey. Verona Pharma plc, listed on Nasdaq under the ticker VRNA, focuses on developing innovative therapies for chronic...

Continue Reading
2024 Luxury Resale Insights from The RealReal

Updated Category News Views 818

Insights from The RealReal's 2024 Luxury Resale Report Consumers Lead the Charge, Redefining Trends and Investing in Lasting Value The RealReal, the largest online marketplace for authenticated resale luxury goods, has unveiled its seventh annual 2024 Luxury Resale Report. This extensive report draws on 13 years of data to analyze the current state of luxury resale,...

Continue Reading